ESMO 2024

Sep 13 - Sep 17, 2024 | Barcelona, Spain

Share this page

Close Tooltip
Copy Link Tooltip

Copy page URL

Long-term follow-up of single-agent divarasib in patients with KRAS G12C-positive solid tumors

Authors Elena Garralda, Manish R. Patel, Tae Won Kim, Adrian Sacher, Martin Forster, Armando Santoro, Jayesh Desai, Luis Paz-Ares, Alejandro Falcon, Maria de Miguel, Samantha Bowyer, Rafal Dziadziuszko, Se Hyun Kim, Sae-Won Han, Matthew G. Krebs, Patricia LoRusso, Rasha Cosman, Julie Chang, Tomi Jun, Wilson H. Miller Jr.

Published date15 September, 2024

Report of long-term safety and clinical activity of single-agent divarasib in patients with advanced KRAS G12C-positive solid tumors.

Download Current View

Welcome to Medically

The Roche Science Hub

This website is a non-promotional global resource intended to facilitate transparent scientific exchange regarding developments in medical research, diagnostics, and disease management.

Not a healthcare professional? Browse:

This website is a non-promotional global resource intended to facilitate transparent scientific exchange regarding developments in medical research, diagnostics, and disease management. This global website is intended for healthcare professionals outside the UK, US, Canada, and Australia. The content on this website may include scientific information about experimental or investigational compounds, indications, and services that are not approved or valid in your country. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website. Information available on this website does not constitute professional medical advice, and Roche and Genentech accept no responsibility for access to or use of the same.

You are Leaving Medically

By following this link, you are leaving Roche Website and entering a site that is not owned or controlled by Roche. Roche does not take any responsibility for acces to or use of this website, nor for any content therein.

You are Leaving the Global Medically Site

By following this link, you are being redirected to another Roche page.